What is all that thrombin for?

Summary.  The hemostatic process initiated by the exposure of tissue factor to blood is a threshold limited reaction which occurs in two distinct phases. During an initiationphase, small amounts of factor (F)Xa, FIXa and thrombin are generated. The latter activates the procofactors FV and FVIII to the activated cofactors which together with their companion serine proteases form the intrinsic FX activator (FVIIIa‐FIXa) and prothrombinase (FVa‐FXa) which generate the bulk of FXa and thrombin during a propagation phase. The clotting process (fibrin formation) occurs at the inception of the propagation phase when only 5‐10 nM thrombin has been produced. Consequently, the vast majority (greater than 95%) of thrombin is produced after clotting during the propagation phase of thrombin generation. The blood of individuals with either hemophilia A or hemophilia B has no ability to generate the intrinsic FXase, and hence is unable to support the propagation phase of the reaction. Since clot based assays conclude before the propagation phase they are not sensitive to hemophilia A and B. The inception and magnitude of the propagation phase of thrombin generation is influenced by genetic polymorphisms associated with thrombotic and hemorrhagic disease, by the natural abundance of pro‐ and anticoagulants in healthy individuals and by pharmacologic interventions which influence thrombotic pathology. Therefore, it is our suspicion that the performance of the entire process of thrombin generation from initiation through propagation and termination phases of the reaction are relevant with respect to both hemorrhagic and thrombotic pathology.

[1]  H. Kwaan.  A History of Blood Coagulation , 2002 .

[2]  K. Mann,et al.  A model for the tissue factor pathway to thrombin. I. An empirical study. , 1994, The Journal of biological chemistry.

[3]  S. Olson,et al.  Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin. , 1993, Methods in enzymology.

[4]  S. Zahler,et al.  Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. , 2001, Biochemical and biophysical research communications.

[5]  K. C. Jones,et al.  A Model for the Stoichiometric Regulation of Blood Coagulation* , 2002, The Journal of Biological Chemistry.

[6]  N. Mackman,et al.  Measurement of Tissue Factor Activity in Whole Blood , 2000, Thrombosis and Haemostasis.

[7]  K. Mann,et al.  Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. , 2001, Blood.

[8]  A. Shibata,et al.  Tissue factor in plasma of patients with disseminated intravascular coagulation , 1994, American journal of hematology.

[9]  K. Mann,et al.  Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa. , 2000, Blood.

[10]  H. Hemker,et al.  Phenotyping the Clotting System , 2002, Thrombosis and Haemostasis.

[11]  B. Osterud,et al.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Broze,et al.  Targeted disruption of the murine tissue factor gene results in embryonic lethality. , 1996, Blood.

[13]  K. Mann,et al.  Factor V: a combination of Dr Jekyll and Mr Hyde. , 2003, Blood.

[14]  K. Mann,et al.  Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism , 2003, Circulation.

[15]  K. Mann,et al.  "Normal" thrombin generation. , 1999, Blood.

[16]  D. Ginsburg,et al.  Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V , 1996, Nature.

[17]  K. Mann,et al.  The factor Xa-catalyzed activation of factor V. , 1983, The Journal of biological chemistry.

[18]  P. Carmeliet,et al.  Blood Coagulation Factor X Deficiency Causes Partial Embryonic Lethality and Fatal Neonatal Bleeding in Mice , 2000, Thrombosis and Haemostasis.

[19]  G. Broze,et al.  Factor XI activation in a revised model of blood coagulation , 1991, Science.

[20]  J. Spivak,et al.  Commentary on and reprint of Davie EW, Ratnoff OD, Waterfall sequence for intrinsic blood clotting, in Science (1964) 145:1310–1311 , 2000 .

[21]  K. Mann,et al.  Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation. , 1991, The Journal of biological chemistry.

[22]  J. Badimón,et al.  Blood-borne tissue factor: another view of thrombosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Mann,et al.  Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. , 1993, The Journal of biological chemistry.

[24]  K. Mann,et al.  The mechanism of inactivation of human factor V and human factor Va by activated protein C. , 1994, The Journal of biological chemistry.

[25]  E. Davie,et al.  Waterfall Sequence for Intrinsic Blood Clotting , 1964, Science.

[26]  K. Mann,et al.  Blood clotting in minimally altered whole blood. , 1996, Blood.

[27]  D. Witte,et al.  Prothrombin deficiency results in embryonic and neonatal lethality in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Miyata,et al.  Expression of human soluble tissue factor in yeast and enzymatic properties of its complex with factor VIIa. , 1992, The Journal of biological chemistry.

[29]  P. Comp,et al.  Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. , 1993, Blood.

[30]  J. Jesty,et al.  Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma. , 1984, Blood.

[31]  K. Brinkhous,et al.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. , 1953, The Journal of laboratory and clinical medicine.

[32]  K. Mann,et al.  A model for the tissue factor pathway to thrombin. II. A mathematical simulation. , 1994, The Journal of biological chemistry.

[33]  K. Mann,et al.  Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. , 1988, Annual review of biochemistry.

[34]  P. Fay,et al.  Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa. Identification of cleavage sites and correlation of proteolysis with cofactor activity. , 1991, The Journal of biological chemistry.

[35]  G. Broze,et al.  Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. , 1997, Blood.

[36]  C. Esmon,et al.  The roles of protein C and thrombomodulin in the regulation of blood coagulation. , 1984, The Journal of biological chemistry.

[37]  P. Carmeliet,et al.  Mice lacking factor VII develop normally but suffer fatal perinatal bleeding , 1997, Nature.

[38]  H. Livingstone.  STEDMAN'S MEDICAL DICTIONARY , 1961, The Ulster Medical Journal.

[39]  K. Mann,et al.  Role of the membrane surface in the activation of human coagulation factor X. , 1992, The Journal of biological chemistry.

[40]  P. Morawitz,et al.  Die Chemie der Blutgerinnung , 1905 .

[41]  K. Mann,et al.  A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition. , 1999, Biochemistry.

[42]  R. Westrick,et al.  Lethal Perinatal Thrombosis in Mice Resulting From the Interaction of Tissue Factor Pathway Inhibitor Deficiency and Factor V Leiden , 2002, Circulation.

[43]  K. Mann,et al.  Antiplatelet agents in tissue factor-induced blood coagulation. , 2001, Blood.

[44]  R. Macfarlane.  An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier , 1964, Nature.

[45]  K. Mann,et al.  Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation , 2001, Circulation.

[46]  G. Broze,et al.  Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor* , 1998, The Journal of Biological Chemistry.

[47]  K. Mann,et al.  Increased Tissue Factor-initiated Prothrombin Activation as a Result of the Arg506 → Gln Mutation in Factor VLEIDEN * , 1997, The Journal of Biological Chemistry.

[48]  V. Wheaton,et al.  Characterization of a functional thrombin receptor. Issues and opportunities. , 1992, The Journal of clinical investigation.

[49]  K. Kurachi,et al.  Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice. , 1998, Blood.

[50]  F. Church,et al.  Leukocyte chemoattractant peptides from the serpin heparin cofactor II. , 1991, The Journal of biological chemistry.

[51]  J. Degen,et al.  Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. , 1995, Genes & development.

[52]  Macfarlane Rg,et al.  AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .

[53]  S. Antonarakis,et al.  Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A , 1995, Nature Genetics.

[54]  K. Mann,et al.  Thrombin functions during tissue factor-induced blood coagulation. , 2002, Blood.

[55]  B. Osterud.  The role of platelets in decrypting monocyte tissue factor. , 2001, Seminars in hematology.

[56]  Kenneth G. Mann,et al.  Inhibitory Mechanism of the Protein C Pathway on Tissue Factor-induced Thrombin Generation , 1997, The Journal of Biological Chemistry.

[57]  A. Giles,et al.  The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets. , 1988, The Journal of biological chemistry.

[58]  K. Mann,et al.  Oral Anticoagulation Thresholds , 2001, Circulation.

[59]  K Fujikawa,et al.  Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. , 1991, The Journal of biological chemistry.

[60]  J. Jesty,et al.  Kinetics of the tissue factor-dependent activation of coagulation Factors IX and X in a bovine plasma system. , 1979, The Journal of biological chemistry.

[61]  D. Tollefsen,et al.  Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. , 1982, The Journal of biological chemistry.

[62]  Kenneth G. Mann,et al.  An Integrated Study of Fibrinogen during Blood Coagulation* , 1999, The Journal of Biological Chemistry.

[63]  J. Delâge.  [Coagulation]. , 2018, Laval medical.

[64]  K. Mann,et al.  Platelets and Phospholipids in Tissue Factor-initiated Thrombin Generation , 2001, Thrombosis and Haemostasis.

[65]  K. Mann,et al.  Blood coagulation in hemophilia A and hemophilia C. , 1998, Blood.

[66]  Kenneth G. Mann,et al.  Regulation of Tissue Factor Initiated Thrombin Generation by the Stoichiometric Inhibitors Tissue Factor Pathway Inhibitor, Antithrombin-III, and Heparin Cofactor-II* , 1997, The Journal of Biological Chemistry.

[67]  P. Carmeliet,et al.  Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. , 1998, The Journal of clinical investigation.

[68]  B. Østerud.  The role of platelets in decrypting monocyte tissue factor. , 2001, Seminars in hematology.